A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 2969-2975

  Kamp, G A ^a   Mul, D ^b   Waelkens, J J J ^c   Jansen, M ^d   Delemarre Van De Waal, H A ^e   Verhoeven Wind, L ^d   Frolich M ^a   Oostdijk, W ^a   Wit, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ESTRADIOL; GONADORELIN AGONIST; HUMAN GROWTH HORMONE; OSTEOCALCIN; PROCOLLAGEN; SOMATOMEDIN B; SOMATOMEDIN C; TESTOSTERONE; TRIPTORELIN;

ADRENAL GLAND; ARTICLE; BODY HEIGHT; BODY MASS; BONE AGE; BONE MATURATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GROWTH RATE; HORMONE DETERMINATION; HUMAN; IDIOPATHIC DISEASE; INTRAUTERINE GROWTH RETARDATION; MALE; PRIORITY JOURNAL; PUBERTY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHORT STATURE; SIDE EFFECT;

ADOLESCENT; AGE DETERMINATION BY SKELETON; BODY HEIGHT; BONE DEVELOPMENT; CHILD; DRUG THERAPY, COMBINATION; ESTRADIOL; FEMALE; FETAL GROWTH RETARDATION; GROWTH; HUMAN GROWTH HORMONE; HUMANS; MALE; PUBERTY; TESTOSTERONE; TREATMENT OUTCOME; TRIPTORELIN;

EID: 0034913704     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.7.2969     Document Type: Article

References (32)

1. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone
2. Effect of growth hormone treatment on adult height of children with idiopathic short stature
3. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial
4. Final height of short normal children treated with growth hormone
5. The effects of growth hormone therapy on spontaneous sexual development
6. Influence of growth hormone treatment on pubertal timing and pubertal growth in children with idiopathic short stature
7. Final height in central precocious puberty after long-term treatment with a slow-release GnRH agonist
8. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogs and growth hormone
9. Final height after long-term treatment with Triptorelin slow release for central precocious puberty: Importance of statural growth after interruption of treatment
10. Failure to improve height prediction in short stature pubertal adolescent by inhibiting puberty with luteinizing hormone-releasing hormone analogue
11. Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development
12. Effects of Deslorelin-induced pubertal delay on the growth of adolescents with short stature and normally timed puberty: Preliminary results
13. Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist
14. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty
15. GH and GnRH analog treatment in children who enter puberty at short stature
16. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone
17. Combination treatment with growth hormone and gonadotropin-releasing hormone analogs in short normal girls
18. Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation
19. Growth diagrams 1980. Netherlands third nation-wide survey
20. Tables for predicting adult height for skeletal age: Revised for use with the Greulich-Pyle hand standards
21. Centiles of body mass index for Dutch children aged 0-20 years in 1980 - A baseline to assess recent trends in obesity
22. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency
23. Using the LMS method to measure skewness in the NCHS and Dutch national height standards
24. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis
25. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: Results of a prospective, randomized trial
26. Spontaneous growth and response to-growth hormone treatment in children with growth hormone deficiency and idiopathic short stature
27. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone
28. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty
29. Editorial: Leptin and puberty
30. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: Theoretic and practical considerations